Rotavirus is surging across the United States, with the Bay Area a significant hotspot, according to wastewater and federal health data. High levels of the virus are being detected in every region except the Midwest, with concentrations also rising sharply in New Jersey, Connecticut, and along the Northeast coast.
Nationwide figures from a U.S. Centers for Disease Control and Prevention dashboard show numbers have climbed steadily since mid-December. The wastewater surveillance, which detects viral material shed in stool, provides an early warning of community transmission for this highly contagious gastrointestinal illness.
Controversial Shift in Vaccine Policy
The current wave arrives amid significant controversy over recent changes to childhood vaccine recommendations. The Trump administration has moved the rotavirus vaccine from a universal recommendation to a “shared clinical decision-making” category. This means parents are now advised to discuss the vaccine with their child’s clinician, rather than it being a standard part of the schedule for all infants.
Health Secretary Robert F. Kennedy, Jr. stated the agency was “aligning the U.S. childhood vaccine schedule with international consensus while strengthening transparency and informed consent.” The American Academy of Pediatrics identified Denmark as a model for this new approach; the Scandinavian nation does not include rotavirus vaccination in its routine childhood programme, viewing the disease as less serious within its healthcare context.
This policy shift has been met with fierce criticism from major medical bodies. Dr. Sean O’Leary, chair of the American Academy of Pediatrics Committee on Infectious Diseases, warned the changes would “bring back suffering and death” without hyperbole. The Academy continues to strongly recommend universal rotavirus vaccination for all children, a position starkly at odds with the new federal guidance. The changes were temporarily blocked in court last month.
Experts stress the danger of underestimating the virus. Dr. Yvonne Maldonado, a professor of pediatrics at Stanford University School of Medicine, noted that people “tend to think that diarrheal disease isn’t a big deal,” but that rotavirus “can actually be very severe in infants and young children.”
Vaccine Effectiveness and Safety
The rotavirus vaccine has a proven track record of drastically reducing severe illness. Before its introduction in the U.S. in 2006, rotavirus was the leading cause of severe diarrhoea among infants and young children, causing an estimated 2.7 million cases annually, 55,000-70,000 hospitalisations, and 20-60 deaths. The CDC states the vaccine has since averted an estimated 45,000 hospitalisations and 342,000 clinic and emergency department visits each year.
There are two oral vaccines for infants in the U.S.: RotaTeq (RV5), given in three doses, and Rotarix (RV1), given in two. They are highly effective, with studies showing 85-98% protection against severe illness requiring hospitalisation in an infant’s first year. The CDC notes that between 94-96% of vaccinated children are protected from hospitalisation.
As with any medicine, the vaccines carry a small risk of side effects. There is a very small associated risk of intussusception, a rare bowel blockage, estimated to affect between one in every 20,000 to one in every 100,000 U.S. infants. The CDC points out this risk is comparable to or lower than the risk from a natural rotavirus infection, which caused approximately 1,900 infants to develop the condition annually before vaccination. The first rotavirus vaccine in the U.S., RotaShield, was withdrawn in 1999 due to higher intussusception concerns.
While the vaccines do not offer full immunity from future infections—children can be infected more than once, with subsequent infections usually milder—they remain the best defence against severe disease. The virus spreads primarily through the fecal-oral route via contaminated hands, surfaces, food, or water, and can also spread through airborne droplets from coughing and sneezing. Symptoms, which include fever, vomiting, and watery diarrhoea for 3-8 days, are most severe during a first infection and pose a particular risk of dehydration to children under five.
Studies indicate a correlation between wastewater concentrations of the virus and vaccination coverage, with areas of higher vaccine uptake tending to experience shorter durations of elevated rotavirus detection.
